Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
IDWeek 2022Updated Moderna Booster More Active Against COVID in AdultsPhase 2/3 results show that the bivalent second booster that targets both the original virus and the Omicron variant was superior to the standard booster a month after vaccination across age groups.
Medscape Medical News, October 21, 2022
IDWeek 2022Monkeypox Presentations, Prevention Strategies ShiftingSpecialists say that infections in the immunocompromised and homeless populations are a growing concern. Early CDC data show that the vaccine is effective.
COVID-19 Updates Dominate IDWeek LineupGlobal vaccine distribution promises to be a hot topic. Experts will also share advances in treating and preventing other
infectious diseases and partnership strategies for developing new antibiotics.
Medscape Medical News, Sep 28, 2021
Oteseconazole Promising for Recurrent Yeast InfectionsA phase 3 trial indicates the drug is safe and effective in treating acute and recurrent cases of acute vulvovaginal candidiasis,
and preventing recurrence of VVC episodes.
Medscape Medical News, Sep 30, 2021
Antibody Cocktail Reduces Chance of Developing COVIDTwo long-acting antibodies — tixagevimab mixed with cilgavimab — reduced the risk of developing symptomatic COVID by 77% in
a phase 3 trial of adults at high risk of contracting the virus.
Medscape Medical News, Oct 01, 2021
Shoe Swabs Find High
C. diff Counts Outside Healthcare Sites
Clostridioides difficile is most often thought of as a disease acquired in healthcare facilities, but researchers find that shoe bottoms tell another
story of transmission in communities.
